Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.
Prescription Trends Between 2019 and 2022 Show the Rise of Telehealth
Diabetes Dialogue: Real-World Experience with the Dexcom Stelo
FDA Approves Dupilumab for Adolescents with Chronic Rhinosinusitis with Nasal Polyps
Diabetes Dialogue: Lingo Availability and FDA Clearance for Embecta's Tubeless Patch Pump
Study Identifies Link Between Maternal Bread Consumption, Risk of Infant Allergies
Cannabis Cream Safely Reduces Itch in Patients with CKD-Associated Pruritus